Paxvax Berna

Infectious disease knows no borders – neither do we.
 

Paxvax is a leading independent vaccine company. We are devoted to developing and commercializing specialty in vaccines that protect against existing and emerging infectious diseases. Our goal is to provide tools for health care providers serving the 100 million people every year who travel to countries where these diseases are present.
 

We achieved a ground-breaking milestone by commercializing the only oral vaccine for typhoid fever (VIVOTIF®). We have a robust pipeline of vaccines at various stages of preclinical and clinical development for adenovirus, chikungunya, hepatitis A, HIV and Zika.
 

As part of our social mission, we are also committed to making our vaccines available for use by the developing world to protect against endemic infectious diseases and ensure we can increase access to these vaccines for the people who need them most.
 

Founded in 2006, Paxvax is a privately held, fully integrated vaccine company, headquartered in Redwood City, California, with sites in San Diego, California and Bern, Switzerland.